1. Home
  2. LEGN vs LAD Comparison

LEGN vs LAD Comparison

Compare LEGN & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • LAD
  • Stock Information
  • Founded
  • LEGN 2014
  • LAD 1946
  • Country
  • LEGN United States
  • LAD United States
  • Employees
  • LEGN N/A
  • LAD N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • LAD Retail-Auto Dealers and Gas Stations
  • Sector
  • LEGN Health Care
  • LAD Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • LAD Nasdaq
  • Market Cap
  • LEGN 7.0B
  • LAD 7.8B
  • IPO Year
  • LEGN 2020
  • LAD 1996
  • Fundamental
  • Price
  • LEGN $32.80
  • LAD $288.55
  • Analyst Decision
  • LEGN Strong Buy
  • LAD Buy
  • Analyst Count
  • LEGN 12
  • LAD 13
  • Target Price
  • LEGN $79.00
  • LAD $375.00
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • LAD 379.5K
  • Earning Date
  • LEGN 05-12-2025
  • LAD 04-23-2025
  • Dividend Yield
  • LEGN N/A
  • LAD 0.74%
  • EPS Growth
  • LEGN N/A
  • LAD N/A
  • EPS
  • LEGN N/A
  • LAD 29.65
  • Revenue
  • LEGN $627,241,000.00
  • LAD $36,188,200,000.00
  • Revenue This Year
  • LEGN $66.92
  • LAD $7.84
  • Revenue Next Year
  • LEGN $51.77
  • LAD $7.80
  • P/E Ratio
  • LEGN N/A
  • LAD $9.73
  • Revenue Growth
  • LEGN 119.97
  • LAD 16.58
  • 52 Week Low
  • LEGN $29.27
  • LAD $243.00
  • 52 Week High
  • LEGN $60.87
  • LAD $405.68
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 45.92
  • LAD 44.40
  • Support Level
  • LEGN $29.27
  • LAD $278.31
  • Resistance Level
  • LEGN $35.11
  • LAD $301.62
  • Average True Range (ATR)
  • LEGN 1.89
  • LAD 17.87
  • MACD
  • LEGN 0.16
  • LAD 1.38
  • Stochastic Oscillator
  • LEGN 60.48
  • LAD 52.72

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About LAD Lithia Motors Inc.

Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.

Share on Social Networks: